Pelvic Lymphadenectomy for Stage B 1 Adenocarcinoma of the Prostate: Justified or Not?
- 1 February 1977
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 117 (2) , 199-200
- https://doi.org/10.1016/s0022-5347(17)58397-4
Abstract
Of 47 patients who underwent staging pelvic lymphadenectomy for clinically localized adenocarcinoma of the prostate, 26 had clinical stage B1 disease. Only 2 of these patients (8%) had positive pelvic nodes. The low incidence of lymphatic spread, the potential complications of lymphadenectomy and the role of regional lymphatics in generating an immunological defense raise the question of the efficacy of lymphadenectomy in the treatment of rigidly defined, clinical stage B1 adenocarcinoma of the prostate.This publication has 8 references indexed in Scilit:
- Prostatic Carcinoma: Incidence and Location of Unsuspected Lymphatic MetastasesJournal of Urology, 1976
- REGIONAL LYMPHADENECTOMY AND TUMOR IMMUNITY1976
- Carcinoma of the Prostate: A Study of 213 Patients with Stage C Tumors Treated by Total Perineal ProstatectomyJournal of Urology, 1975
- Pelvic Lymphadenectomy for Staging Localized Prostatic CancerJournal of Urology, 1974
- Implantation of 125I in Prostatic CancerSurgical Clinics of North America, 1974
- The Value of Pelvic Lymphadenectomy in the Surgical Treatment of Bladder CancerJournal of Urology, 1973
- Hormone therapy in prostatic cancerThe American Journal of Medicine, 1956
- Radical mastectomy in continuity with en bloc resection of the internal mammary lymph-node chain.A new procedure for primary operable cancer of the breastCancer, 1952